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Abstract
Pseudomonas aeruginosa is a nearly ubiquitous human pathogen, and infections can be lethal to patients with impaired
respiratory and immune systems. Prior studies have established that strong loss-of-function mutations in the egl-9 gene
protect the nematode C. elegans from P. aeruginosa PAO1 fast killing. EGL-9 inhibits the HIF-1 transcription factor via two
pathways. First, EGL-9 is the enzyme that targets HIF-1 for oxygen-dependent degradation via the VHL-1 E3 ligase. Second,
EGL-9 inhibits HIF-1-mediated gene expression through a VHL-1-independent mechanism. Here, we show that a loss-of-
function mutation in hif-1 suppresses P. aeruginosa PAO1 resistance in egl-9 mutants. Importantly, we find stabilization of
HIF-1 protein is not sufficient to protect C. elegans from P. aeruginosa PAO1 fast killing. However, mutations that inhibit both
EGL-9 pathways result in higher levels of HIF-1 activity and confer resistance to the pathogen. Using forward genetic
screens, we identify additional mutations that confer resistance to P. aeruginosa. In genetic backgrounds that stabilize C.
elegans HIF-1 protein, loss-of-function mutations in swan-1 increase the expression of hypoxia response genes and protect
C. elegans from P. aeruginosa fast killing. SWAN-1 is an evolutionarily conserved WD-repeat protein belonging to the AN11
family. Yeast two-hybrid and co-immunoprecipitation assays show that EGL-9 forms a complex with SWAN-1. Additionally,
we present genetic evidence that the DYRK kinase MBK-1 acts downstream of SWAN-1 to promote HIF-1-mediated
transcription and to increase resistance to P. aeruginosa. These data support a model in which SWAN-1, MBK-1 and EGL-9
regulate HIF-1 transcriptional activity and modulate resistance to P. aeruginosa PAO1 fast killing.
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Introduction
Pseudomonas aeruginosa is a ubiquitous bacterial pathogen that can
infect a wide range of animals and plants, and hospital-acquired P.
aeruginosa infections are often lethal to patients with respiratory
ailments or immune system dysfunction [1,2]. The cyanide
produced by P. aeruginosa is thought to contribute to the potentially
devastating effects of P. aeruginosa respiratory infections in cystic
fibrosis patients [3]. Antibiotic-resistant strains of P. aeruginosa are
becoming more prevalent, and it is increasingly important to
understand the pathogenicity of this microbe and the mechanisms
that enable resistance [4,5].
During infection and inflammation, multicellular tissues must
adapt to changing levels of oxygen. The hypoxia-inducible factor
(HIF) transcription complex mediates most of the transcriptional
responses to hypoxia (low oxygen) [6,7]. While HIF transcription
complexes have been shown to play key roles in mammalian
innate immunity, the mechanisms by which HIF regulatory
networks influence pathogenicity and disease progression are not
yet fully understood [8,9,10,11,12].
In recent years, the nematode Caenorhabditis elegans has emerged
as a powerful genetic system to study innate immunity and
resistance to bacterial pathogens [13,14,15,16,17,18]. Many of the
genes that contribute to C. elegans pathogen resistance are
evolutionarily conserved [19,20,21]. Interestingly, there is a strong
correlation between C. elegans genes that mediate resistance to
bacterial pathogens and genes that protect C. elegans from stresses
and extend lifespan [22,23,24,25,26].
Loss-of-function mutations in the C. elegans egl-9 gene enable the
animals to survive fast killing by P. aeruginosa PAO1 [27,28]. While
some Pseudomonas strains (such as PA14 on NGM growth media)
kill C. elegans slowly through colonization in the gut, logarithmically
growing P. aeruginosa PAO1 emits cyanide and kills C. elegans within
hours [14,27,28,29]. C. elegans egl-9 mutants are also resistant to
Crystal or Vibrio cholerae pore-forming toxins [30]. The egl-9 gene
encodes a 2-oxoglutarate-dependent dioxygenase that hydroxyl-
ates the HIF-1 transcription factor. Once HIF-1 is hydroxylated, it
interacts with the VHL-1 E3 ligase and is targeted for proteasomal
degradation [31]. EGL-9 has also been shown to inhibit HIF-1
transcriptional activity via a vhl-1-independent pathway that has
little or no requirement for EGL-9 hydroxylase activity [32,33].
Moderate over-expression of HIF-1 has been shown to increase
resistance to heat and to increase adult longevity in C. elegans
[34,35,36,37].
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In this study, we directly test the hypothesis that increased
expression and activation of the HIF-1 transcription factor in egl-9
mutants protect C. elegans from P. aeruginosa PAO1 fast killing. We
show that resistance to P. aeruginosa fast killing requires both
stabilization of HIF-1 protein and derepression of HIF-1-mediated
gene expression. Using forward genetic screens, we identify
additional mutations that confer resistance to P. aeruginosa PAO1
fast killing. This leads to the discovery that SWAN-1 inhibits HIF-
1 transcriptional activity and modulates resistance to P. earuginosa
PAO1 fast killing. SWAN-1 is an evolutionarily conserved protein
with WD40 repeats [38]. Further, we demonstrate that SWAN-1
interacts with EGL-9 protein in yeast two-hybrid and co-
immunoprecipitation studies.
Results
hif-1 is required for the egl-9-mediated resistance to
PAO1 fast killing
The egl-9(sa307) strong loss-of-function mutation has been
shown to protect C. elegans from P. aeruginosa PAO1 fast killing
[27,28] As shown in Figure 1A, wild-type animals are paralyzed
when placed on P. aeruginosa PAO1, while egl-9 mutant animals
remain motile for several hours. We tested the hypothesis that egl-
9-mediated resistance to fast killing required hif-1 function. As
shown in Figure 1A, the hif-1(ia04) loss-of-function allele totally
suppressed the egl-9-mediated resistance phenotype. The rate at
which the egl-9, hif-1 double mutant was killed by the pathogen
was very similar to the killing curves for wild-type or hif-1(ia04)
animals (Figure 1A, Text S1). A prior study had shown that the
fast killing of C. elegans by P. aeruginosa required cyanide synthesis
[27]. Consistent with this, we found that while P. aeruginosa PAO1
killed wild-type or hif-1-deficient C. elegans within 2 hours, the
hydrogen cyanide synthase mutant P. aeruginosa MP507 did not kill
C. elegans in this time interval (Text S1).
We next investigated which EGL-9 functions were most critical
to the P. aeruginosa PAO1 fast killing phenotype. EGL-9 regulates
HIF-1 via at least two pathways: EGL-9 is the oxygen-sensitive
enzyme that targets HIF-1 protein for degradation through the
VHL-1 pathway, and EGL-9 inhibits HIF-1-mediated transcrip-
tional activity by a vhl-1-independent mechanism [32,33,39]. We
first tested the hypothesis that stabilization of HIF-1 protein was
sufficient to increase resistance to P. aeruginosa PAO1 fast killing.
The HIF-1(P621G) mutation precludes hydroxylation of HIF-1 by
EGL-9 and stabilizes HIF-1 protein [31,32,34]. We assayed four
transgenic strains, each expressing either wild-type HIF-1 or the
HIF-1(P621G) stabilized protein. Remarkably, none of the
transgenic strains were resistant to P. aeruginosa PAO1, as they
died at rates similar to wild-type animals (Figure 1B, Text S1).
Consistent with this result, the vhl-1(ok161) mutation did not
protect C. elegans from fast killing (Text S1).
Author Summary
Pseudomonas aeruginosa is a common bacterial pathogen
that can infect a wide range of animals. In some
conditions, P. aeruginosa produces cyanide, a toxin that
limits cellular capacity to metabolize oxygen and produce
energy. The nematode Caenorhabditis elegans is a power-
ful genetic model system for understanding the mecha-
nisms of stress response and pathogen resistance. Here,
we show that HIF-1, a DNA-binding transcription factor
that mediates cellular responses to low oxygen, can
protect C. elegans from P. aeruginosa fast killing. Addition-
ally, we identify swan-1 as a gene that functions to inhibit
HIF-1 activity and suppress P. aeruginosa resistance. The
SWAN-1 protein binds directly to the oxygen-sensing EGL-
9 enzyme that controls HIF-1 stability and activity. This
study advances understanding of HIF-1 regulatory net-
works, defines connections between hypoxia response and
P. aeruginosa fast killing, and provides new insights into
mechanisms by which animals can resist this bacterial
pathogen.
Figure 1. egl-9-mediated resistance to Pseudomonas aeruginosa PAO1 fast killing is mediated by hif-1. A. Percent C. elegans survival over
time on P. aeruginosa PAO1. Wild-type N2 and hif-1 mutants exhibit similar sensitivity to fast killing (.50% dead by 40 minutes), but 100% of animals
carrying a strong loss-of-function mutation in egl-9 survived after 2 hours. The P. aeruginosa resistance phenotype conferred by egl-9(sa307) was
suppressed by the hif-1(ia04) strong loss-of-function allele. B. Stabilization of HIF-1 protein was not sufficient to confer resistance to P. aeruginosa
PAO1 fast killing. The survival curves for strains expressing epitope-tagged HIF-1 or stabilized HIF-1(P621G) were similar to that of the wild-type strain.
Three independently generated transgenic strains expressing HIF-1(P621G) were assayed. Each experiment was repeated at least three times with 30–
50 animals for each strain. The error bars represent standard errors. These data are also presented in tabular format in Text S1.
doi:10.1371/journal.ppat.1001075.g001
HIF-1-Mediated Resistance to P. aeruginosa
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Genetic screens identify mutations in swan-1 and rhy-1
that increase HIF-1-mediated transcription and protect
C. elegans from P. aeruginosa PAO1 fast killing
The results thus far suggested that resistance to fast killing
required multiple EGL-9 functions. To gain insight to the
mechanisms by which EGL-9 repressed HIF-1 transcriptional
activity and to better understand P. aeruginosa PAO1 pathogenicity,
we conducted forward genetic screens. Using chemical or
transposon-mediated mutagenesis, we screened for mutations in
C. elegans that caused dramatic over-expression of HIF-1 target
genes. As a primary screen, we assayed for the increased
expression of Pnhr-57::GFP, a reporter that is expressed at very
low levels in wild-type animals and is expressed at high levels in egl-
9 mutants [32,33]. These screens identified novel loss-of-function
mutations in rhy-1 (Text S1). Prior studies had shown that rhy-1
encoded a multipass transmembrane protein, and loss-of-function
mutations in rhy-1 had been shown to elevate hif-1 mRNA levels
slightly and to increase HIF-1 transcriptional activity [33]. As
shown in Table 1, animals that lacked rhy-1 function were resistant
to P. aeruginosa PAO1 fast killing, and rhy-1-mediated resistance was
completely suppressed by the hif-1(ia04) strong loss-of-function
mutation.
Reasoning that the effects of some mutations that derepressed
HIF-1 activity might only be evident if HIF-1 protein were stable,
we crossed a vhl-1 loss-of-function mutation into the parental strain
and screened for mutations that increased expression of the
reporter. One such screen identified ia50, a mutation that
enhanced expression of the Pnhr-57::GFP reporter in vhl-1(ok161)
mutants (compare Figure 2C to 2B). While vhl-1(ok161) animals
over-expressed the reporter in the intestine, the ia50 mutation
expanded expression of Pnhr-57::GFP to other tissues, including
the hypodermis and the excretory cell (Figure 2C). The enhanced
GFP expression phenotype of ia50 was completely recessive. The
ia50, vhl-1(ok161) double mutants had morphological defects that
were similar to those seen in egl-9 loss-of-function mutants,
including egg-laying defects (data not shown). Additionally, both
strains exhibited reduced fertility (Figure 2G).
Genetic mapping with single-nucleotide polymorphisms placed
ia50 near +5.67 map units on chromosome five of the C. elegans
Table 1. Loss-of-function mutations in egl-9 or rhy-1 confer resistance to P. aeruginosa PAO1 fast killing.
Strains Survival rate after 4 hours Total animals Experimental replicates
N2 361% 178 5
rhy-1(ok1402) 9366% 178 5
rhy-1(ok1402) hif-1(ia04) 060% 142 4
egl-9(sa307) 10060% 177 3
egl-9(ia60) 10060% 91 4
egl-9(ia58) 10060% 67 2
rhy-1(ia59) 10060% 123 3
rhy-1(ia63) 9961% 143 3
rhy-1(ia64) 10060% 112 2
rhy-1(ia62) 9661% 71 2
doi:10.1371/journal.ppat.1001075.t001
Figure 2. Phenotypic characterization of the ia50 mutation. The ia50 allele was isolated in a genetic screen for mutations that increased
expression of Pnhr-57::GFP in animals expressing stabilized HIF-1. A – F. Fluorescent images are shown in A, B, C, and the corresponding DIC images
are in D, E, F. A, D. Wild-type animals express the reporter at very low levels. B, E. In animals carrying the vhl-1(ok161) strong loss-of-function
mutation, HIF-1 protein is stable, and the reporter is expressed throughout the intestine. C, F. ia50 vhl-1(ok161) double mutants express the reporter
at higher levels and in more tissues, including the excretory cell and the hypodermis. Asterisks mark the position of the excretory cell, near the
posterior bulb of the pharynx in the head. The scale bar represents 0.1 mm. G. Total brood sizes (numbers of progeny) were lower in egl-9-deficient
animals and in double mutants carrying loss-of-function mutations in both vhl-1 and swan-1, compared to wild-type C. elegans.
doi:10.1371/journal.ppat.1001075.g002
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genome (Figure 3A). Cosmid rescue experiments further delimited
a genomic region that could restore a wild-type Pnhr-57::GFP
expression pattern to ia50 mutant animals (Figure 3A). We
sequenced the genes in this region and found that ia50 mutants
carried a single nucleotide mutation in the splice acceptor site for
swan-1 (F53C11.8) exon 3 (Figure 3A, 3B). Full-length cDNA
sequencing confirmed that ia50 mutants did not splice intron 2
from the swan-1 mRNA, and this introduced an early stop codon.
The gene name swan-1 means ‘‘seven WD repeats, AN11 family’’,
and this family of genes includes Petunia AN11, Arabidopsis
TTG1, zebrafish Wdr68, and human HAN11 [40,41,42,43]. WD
repeat proteins have beta propeller tertiary structures and often
serve as platforms for the assembly of larger protein complexes.
The swan-1(ia50) mutant allele is predicted to encode a truncated
protein including only 2 of the WD repeats, and this suggests that
it is a loss-of-function mutation.
To further test the hypothesis that the ia50 mutant phenotype
was due to defects in the swan-1 gene, we used bacterially mediated
RNAi to deplete swan-1 mRNA. swan-1 RNAi increased the
expression of Pnhr-57::GFP, as assayed by protein blots. In control
experiments, RNAi for a neighboring gene, swan-2, did not change
the expression of the reporter (compare to the empty vector
control in Figure 3C).
Prior studies had characterized the swan-1(ok267) deletion
mutation as a strong loss-of-function allele [38] (illustrated in
Figure 3A). When HIF-1 protein was stabilized by the vhl-1(ok161)
mutation, the swan-1(ok267) allele increased expression of the Pnhr-
57::GFP reporter (Figure 3D). This phenotype was suppressed by a
loss-of-function mutation in hif-1. The swan-1 deletion allele also
reduced fertility in a vhl-1 mutant background (Figure 2G). These
similarities between the swan-1(ia50) and swan-1(ok267) pheno-
types provided additional support for the conclusion that ia50 was
a loss-of-function mutation in the swan-1 gene. For more in-depth
analyses of swan-1 function, we used the swan-1(ok267) deletion
allele, as it had been characterized in prior studies [38].
Having established that swan-1 negatively regulated Pnhr-
57::GFP expression, we next asked whether a strong loss-of-
function mutation in swan-1 also increased the expression of other
HIF-1 target genes. Prior studies had demonstrated that
K10H10.2 and F22B5.4 were induced by hypoxia in a hif-1-
dependent manner and that they were over-expressed in vhl-1, egl-
9, or rhy-1 loss-of-function mutants [31,32,33,39]. As shown in
Figure 4A and 4B, mRNA levels for both K10H10.2 and F22B5.4
increased in swan-1(ok267), vhl-1(ok161) double mutants, relative to
the vhl-1(ok161) single mutants. These data represent at least three
biological replicates of realtime RT-PCR experiments. As shown
in Figure 4C, the swan-1 deletion mutation did not have a
significant effect on HIF-1 protein levels.
In the presence of stabilized HIF-1, a swan-1 loss-of-
function mutation protected C. elegans from
P. aeruginosa fast killing
We hypothesized that the combination of HIF-1 stabilization
and deletion of swan-1 might result in a P. aeruginosa resistance
phenotype similar to that of egl-9 or rhy-1 mutants. Stabilization of
HIF-1, through either the stabilizing P621G mutation in HIF-1
transgenes or by mutation of the vhl-1 E3 ligase, was not sufficient
to protect C. elegans from P. aeruginosa PAO1 fast killing (Figure 1B
and 5A). However, swan-1(ok267), vhl-1(ok161) double mutants
were much more resistant than wild-type animals (.40% survived
after two hours) (Figure 5A and Text S1). As expected, this
resistance was suppressed by a hif-1 loss-of-function mutation (Text
S1). Similarly, in transgenic animals expressing HIF-1(P621G), the
swan-1(ok267) mutation enabled almost 100% survival after two
hours on a P. aeruginosa PAO1 lawn (Figure 5B). Similar results
were obtained using an independent hif-1(P621G) transgenic line
(Text S1).
Interaction between the EGL-9 and SWAN-1 proteins
Since the genetic data suggested that SWAN-1 and EGL-9
acted in concert to inhibit HIF-1 activity, we next asked whether
Figure 3. ia50 is a loss of function mutation in the swan-1 gene.
A. Genetic mapping of the ia50 mutation. Three-point mapping with
the indicated single nucleotide polymorphisms placed ia50 at +5.67 mu
on chromosome V. Injection of a pool of 3 cosmids in the region
(F20G2, F53C11, and F55B12) rescued the ia50 homozygous mutants, as
assayed by Pnhr-57::GFP expression. This region includes the swan-1
gene. swan-1(ok267) is a deletion mutation. B. ia50 mutants carry a
point mutation at the 39 end of intron 2 of swan-1. This results in failure
to splice out intron 2 from the mRNA and introduces an early stop
codon, illustrated by an asterisk. C. Depletion of swan-1 by bacterially-
mediated RNAi increased expression of the Pnhr-57::GFP reporter, as
assayed by protein blots. In control experiments, RNAi for the related
swan-2 gene did not alter Pnhr-57::GFP levels. D. The swan-1(ok267)
mutation increased expression of the Pnhr-57::GFP reporter in vhl-
1(ok161) animals, and this phenotype was suppressed by the hif-1(ia04)
strong loss-of-function mutation. Pnhr-57::GFP levels were assayed by
protein blots, and the error bars represent standard errors. **: P,0.01.
doi:10.1371/journal.ppat.1001075.g003
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PLoS Pathogens | www.plospathogens.org 4 August 2010 | Volume 6 | Issue 8 | e1001075
the two proteins interacted directly. To address this, we performed
yeast-two-hybrid assays. In these assays, the EGL-9 catalytic
domain was fused to the GAL4 DNA binding domain. In control
experiments, this protein fusion by itself did not activate expression
of reporter genes that were positively regulated by GAL4 upstream
activating sequences. When the EGL-9 protein fusion was
combined with a protein containing SWAN-1 fused to the
GAL4 activation domain, the two proteins interacted to allow
yeast growth on nutrient deficient plates (-Ade/-His/-Leu/-Trp)
and to activate a-galactosidase expression (Figure 6A). To further
define the regions of SWAN-1 that interacted with EGL-9, we
assayed five SWAN-1 deletions, and these results are summarized
in Figure 6B. A construct containing only the first three WD
repeats of SWAN-1 was able to interact strongly with EGL-9 in
yeast two-hybrid assays, whereas a construct that lacked the first
four WD repeats did not interact with EGL-9.
To further test the hypothesis that EGL-9 and SWAN-1 could
interact in a common complex, we conducted co-immunoprecip-
itation studies. In these experiments, the EGL-9 catalytic domain
was fused to maltose binding protein and expressed in E. coli. A
SWAN-1::GFP fusion protein was expressed in C. elegans and
purified with a GFP-specific monoclonal antibody coupled to
Sepharose beads. In control experiments, GFP alone was purified
from worms. To assess interactions, the SWAN-1::GFP and
MBP::EGL-9 proteins were co-incubated. Then, GFP-interacting
proteins were isolated, and unbound proteins were washed away.
As shown in Figure 6C, MBP::EGL-9 was coimmunoprecipitated
with SWAN-1::GFP.
Prior studies had demonstrated that SWAN-1 interacted with
Rac GTPases and the Rac effector UNC-115, and swan-1 had
been shown to repress Rac GTPase activity in neurons [38]. Thus,
we considered models in which swan-1 repressed HIF-1 activity by
inhibiting Rac GTPases. However, depletion of unc-115, rac-2, ced-
10 or mig-2 by mutation or RNAi did not abolish the induction of
Pnhr-57::GFP expression in swan-1(ok267), vhl-1(ok161) animals
(Text S1). This suggested that SWAN-1 had at least two functions:
it interacted with Rac GTPases in neurons to regulate cell
migration, and it inhibited HIF-1 transcriptional activity, probably
through interaction with EGL-9.
Mutation of mbk-1/DYRK suppresses the swan-1 mutant
phenotype
Homologs of SWAN-1 have been shown to interact with
DYRK dual-specificity tyrosine-phosphorylation regulated kinases
in yeast, zebrafish, and mammalian systems [42,44]. We
hypothesized that swan-1 could interact with a DYRK homolog
to regulate HIF-1 transcriptional activity. To test this, we used
bacterially-mediated RNAi to knock down the expression of mbk-1,
hpk-1 and E02H4.3, three C. elegans genes homologous to
mammalian DYRK genes. As shown in Figure 7A, mbk-1 RNAi
suppressed Pnhr-57::GFP expression in swan-1(ok267), vhl-1(ok161)
double mutants, while the other two RNAi treatments did not.
Interestingly, mbk-1 RNAi did not inhibit expression of the
reporter in egl-9 mutant animals (Figure 7B). We obtained similar
results using the mbk-1(pk1389) loss-of-function mutation
(Figure 7C). The mbk-1 deletion allele also inhibited Pnhr-
57::GFP expression in swan-1(ok267) animals expressing the hif-
1(P621G) transgene (Figure 7D).
We next asked whether mbk-1 contributed to swan-1-mediated P.
aeruginosa PAO1 resistance. As shown in Figure 7E and Text S1,
the mbk-1(pk1389) mutation completely suppressed the PAO1 fast
killing resistance phenotype in swan-1(ok267), vhl-1(ok161) double
mutant animals. Further, mbk-1(pk1389) reduced PAO1 resistance
in the swan-1(ok267), hif-1(P621G) genetic background, as assayed
in two independently isolated hif-1(P621G) transgenic lines
(Figure 7F and Text S1). Interestingly, egl-9 mbk-1 double mutants
are highly resistant to fast killing (Text S1). Thus, in assays of Pnhr-
57::GFP or P. aeruginosa PAO1 fast killing, the mbk-1 mutation
suppresses the swan-1 vhl-1 double mutant phenotype, but not the
egl-9 loss-of-function phenotype.
Discussion
HIF-1 protects C. elegans from P. aeruginosa PAO1 fast
killing
Mutations, alone or in combination, that dramatically increase
HIF-1-mediated gene expression can protect C. elegans from P.
aeruginosa PAO1 fast killing. Prior studies had discovered that loss-
of-function mutations in egl-9 conferred resistance to P. aeruginosa
PAO1 fast killing and to cyanide poisoning, but the role of hif-1
Figure 4. Loss-of-function mutations in swan-1 increase expres-
sion of additional HIF-1 target genes, but do not alter HIF-1
protein levels. A, B. The expression levels of two HIF-1 target genes,
F22B5.4 and K10H10.2, were assayed by quantitative RT-PCR. HIF-1
protein was stabilized by the vhl-1(ok161) mutation. For both genes
assayed, the swan-1(ok267) mutation increased mRNA expression, and
this phenotype was suppressed by the hif-1(ia04) loss-of-function
mutation. The bars represent means from 3 independent replicates, and
error bars reflect standard errors. C. The swan-1(ok267) mutation did
not change HIF-1 protein levels, as assayed by protein blots in three
biological replicates. n. s.: not significant; ** p,0.01.
doi:10.1371/journal.ppat.1001075.g004
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had not been investigated [27,28]. Here, we establish that the
resistance of egl-9 mutants to this pathogen is dependent upon hif-1
function (Figure 1A). EGL-9 is a bifunctional protein, and it
regulates both HIF-1 protein stability and HIF-1 transcriptional
activity [32,33] (Figure 8). Interestingly, we find that stabilization
of HIF-1 protein is not sufficient to protect C. elegans from P.
aeruginosa fast killing, but mutations that disable both EGL-9
pathways confer resistance. We propose that over-expression of
HIF-1 targets beyond a threshold level protects C. elegans from the
cyanide produced by P. aeruginosa PAO1. It is also possible that
mutation of egl-9 allows HIF-1-mediated transcription in specific
cells or tissues that are especially important to this resistance
phenotype.
Hydrogen cyanide is an inhibitor of cytochrome c oxidase, and
it is a potent toxin. The cyanide produced by P. aeruginosa in cystic
fibrosis patients is recognized as a clinically important virulence
factor [3]. Cyanide inhibits cytochrome c oxidase, severely
disabling ATP synthesis through oxidative phosphorylation.
Interestingly, egl-9 mutant animals are also resistant to hydrogen
sulfide, and H2S is also a cytochrome c oxidase inhibitor [45,46].
A parsimonious explanation is that persistent over-expression of
HIF-1 targets protects C. elegans from cyanide or hydrogen sulfide
treatments that disable oxidative phosphorylation. These findings
introduce an important question: which HIF-1 target genes protect
C. elegans from P. aeruginosa PAO1 fast killing, cyanide exposure,
and/or hydrogen sulfide? Prior studies have investigated the genes
induced by short-term moderate hypoxia at 0.1% oxygen for
4 hours at room temperature [6]. Future studies will examine the
changes in gene expression that are common to mutants or mutant
combinations that activate HIF-1 and confer resistance to P.
aeruginosa.
Increased expression of HIF-1 targets has been shown to protect
C. elegans from diverse pathogens or stresses [30,36,37,45,47].
Bellier et al. isolated a loss-of-function mutation in egl-9 in a screen
for mutations that protected C. elegans from pore-forming toxins
[30]. egl-9 mutants have also been shown to be resistant to
enteropathogenic E. coli E2348/69 [47]. Additionally, mutations
that stabilize HIF-1 or increase expression of HIF-1 targets have
been shown to increase C. elegans resistance to polyglutamine or
beta-amyloid toxicity and heat stress [30,34,36,37]. It is not yet
known whether the same HIF-1 targets mediate all of these
resistance phenotypes, but we anticipate that each of these
functions may require multiple direct and indirect HIF-1 targets.
SWAN-1, a novel regulator of HIF-1
SWAN-1 is an evolutionarily conserved WD-repeat protein of
the AN11 family [38]. The data presented here show that SWAN-
1 represses HIF-1-mediated gene expression, but does not control
HIF-1 protein levels. While swan-1 RNAi does increase expression
of the Pnhr-57:GFP reporter in an otherwise wild-type background
(Figure 3C), loss of swan-1 function alone is not sufficient to confer
resistance to cyanide released by P. aeruginosa PAO1 (Figures 5A
and 5B). Resistance to fast killing requires a second mutation that
protects HIF-1 protein from oxygen-dependent degradation.
Double mutants that carry a loss-of-function mutation in swan-1
and a mutation that stabilizes HIF-1 protein are phenotypically
similar to egl-9 loss-of-function mutants, as assayed by fertility, egg
laying defects, over-expression of HIF-1 targets, and resistance to
P. aeruginosa fast killing (Figures 1A, 2G, 4A, 4B, 5A). swan-1, vhl-1
double mutants also exhibit increased resistance to hydrogen
cyanide (unpublished data). Importantly, we show that SWAN-1
forms a complex with EGL-9 (Figure 6A, 6C). Collectively, these
data suggest that SWAN-1 and EGL-9 interact directly to repress
HIF-1 transcriptional activity.
The AN11 family is evolutionarily conserved, and comparative
studies may provide important insights to the roles of these
proteins in stress resistance and transcriptional regulation. Petunia
AN11 interacts with a MYB family transcription factor, and the
human HAN11 gene has been shown to partially rescue the
Petunia an11 mutant phenotype [43]. In human cells, zebrafish,
and in yeast, AN11 homologs have been shown to form complexes
with DYRK kinases [42,44,48]. There are five DYRK members in
mammals: DYRK1A, DYRK1B, DYRK2, DYRK3 and DYRK4
[49]. Of these, DYRK1A has been characterized most extensively,
and it is associated with Down Syndrome [50,51,52]. DYRK1A is
a multifunctional protein and has more than two dozen targets or
interacting proteins, including GLI1, STAT3, and eIF2Be [49].
Figure 5. The swan-1 (ok267), vhl-1 (ok161) double mutant is more resistant to P. aeruginosa PAO1 fast killing than either single
mutant. A, B. Percent C. elegans survival over time on P. aeruginosa PAO1. A. vhl-1(ok161), swan-1(ok267) double mutant animals were resistant to
the fast killing by P. aeruginosa, PAO1 (,40% survival after 2 hours). vhl-1(ok161) or swan-1(ok267) single mutants were not resistant. B. The swan-1
(ok267) mutation increased resistance to P. aeruginosa PAO1 fast killing in animals expressing stabilized HIF-1 protein. Each point on the line graph
represents a mean from at least 3 replicate experiments. The error bars represent standard errors. These data are presented in tabular format in Text
S1.
doi:10.1371/journal.ppat.1001075.g005
HIF-1-Mediated Resistance to P. aeruginosa
PLoS Pathogens | www.plospathogens.org 6 August 2010 | Volume 6 | Issue 8 | e1001075
HAN11 was shown to decrease DYRK1A-mediated phosphory-
lation of GLI1 in a HEK293T cell line [53].
The genetic analyses presented here suggest that in the absence
of SWAN-1, MBK-1/DYRK activates HIF-1 (illustrated in
Figure 8). Specifically, a loss-of-function mutation in mbk-1
suppresses the swan-1, vhl-1 double mutant phenotypes, as assayed
by expression of Pnhr-57::GFP expression and by P. aeruginosa
PAO1 fast killing (Figure 7). These genetic data suggest that mbk-1
acts downstream of swan-1. Interestingly, mutation of mbk-1 does
not suppress the egl-9 mutant phenotype (Text S1). There are at
least two models that could explain these findings. First, EGL-9-
mediated repression of HIF-1 transcriptional activity may be
modulated by SWAN-1 and MBK-1 without being totally
dependent upon these regulators. An alternative model is that
MBK-1 and SWAN-1 act in parallel to EGL-9 to repress HIF-1
activity. While we favor the first model, we recognize both
possibilities in Figure 8. A goal for future studies will be to identify
the targets of MBK-1/DYRK to better understand how MBK-1
promotes HIF-1 activity.
A long-term goal will be to understand how hypoxia-induced
gene expression influences the progression of P. aeruginosa
infections. P. aeruginosa can survive in anaerobic environments,
and the formation of biofilms likely restricts oxygen availability to
infected tissues in human patients. Our findings in C. elegans
suggest that pharmacological inhibitors of the HIF prolyl
hydroxylases might contribute to combinatorial therapies to
protect cells from the cyanide produced by P. aeruginosa PAO1.
Materials and Methods
Alleles and worm culture
C. elegans were grown at 20uC using standard methods, unless
other culture conditions are specified [54]. The loss-of-function
alleles and transgenic lines used in this study are listed in Text S1.
The swan-1(ok267) mutant allele was backcrossed to wild-type
animals three times prior to phenotypic analyses [38].
Mutagenesis
The EMS forward genetic screen was performed as described
previously [33]. Briefly, the parental strain carrying Pnhr-57::GFP
and vhl-1(ok161) was mutagenized with EMS, and the F2 progeny
were screened for increased expression of the Pnhr-57::GFP
reporter using fluorescent stereomicroscopy. We generated the
rhy-1 loss-of-function alleles ia59, ia62, ia63, ia64 in a screen for
Mos1 transposon-mediated mutations that caused Pnhr-57::GFP
overexpression. The methods for Mos1 mobilization have been
described previously [32,55].
Mapping ia50 to the swan-1 locus
The ia50 mutant allele was out-crossed twice to the parental
strain prior to any further mapping or characterization. Chromo-
some and interval mapping were performed as described
previously using single-nucleotide polymorphisms (SNPs) between
the Bristol N2 and Hawaiian strains [56]. Briefly, the iaIs07 (Pnhr-
57::GFP) transgene and the vhl-1(ok161) mutation were crossed
extensively into the Hawaiian genetic background. The resulting
males were crossed to ia50 vhl-1(ok161) double mutants carrying
the iaIs07(Pnhr-57::GFP) marker. Fifty F2 animals exhibiting the
vhl-1, ia50 double mutant phenotype and fifty animals exhibiting
the vhl-1 (ok161) single mutant phenotype (intestinal GFP
expression) were picked into separate tubes, and genomic DNA
was prepared. Analyses of the divergent SNPs showed enrichment
of Bristol bands in mutant lanes and an enrichment of Hawaiian
bands in non-mutant lanes for SNPs lying between -5 and +13 mu
on chromosome V. For interval mapping, individual self-progeny
of F1 hermaphrodites (described above) with the double mutant
phenotype were picked into a 96-well plate to prepare the genomic
DNA, and four SNPs were analyzed (25, +1, +6, +13) [56]. We
then used two SNPs, R10D6 (+5.83 mu) and pkP5086 (+6.42 mu),
to do three point mapping of the ia50 mutation.
Figure 6. SWAN-1 binds to EGL-9. A. In yeast two-hybrid assays,
SWAN-1 interacted with EGL-9, as assayed by growth on Ade2/His2/
Leu2/Trp2 media and by a-galactosidase activity with 16, 106, 1006,
10006dilution from left to right. In control experiments, yeast with the
bait and prey vectors without inserts (pGADT7 and pGBKT7) did not
grow in these conditions. B. SWAN-1 deletions were assayed for
interaction with EGL-9 in the yeast two-hybrid system. The relative
positions of seven evolutionary conserved WD domains, one degener-
ate WD domain (labeled WD?) and the C-terminal domain (CTD) are
indicated. b-galactosidase activity and growth were scored in at least 3
replicates for each construct, and the strength of the interactions were
assessed by comparison to the empty vector pGADT7 negative control
(++: p,0.0001; +: 0.000,p,0.05, 2: p.0.05). The amino-terminal
domain of SWAN-1 containing 3 WD repeats interacted strongly with
EGL-9. C. In additional interaction studies, the SWAN-1::GFP protein
fusion or GFP was immunoprecipitated from transgenic worms with
GFP-specific antibodies coupled to Sepharose beads and then
incubated with bacterially-expressed EGL-9 fused to maltose binding
protein (MBP::EGL-9). MBP::EGL-9 co-purified with SWAN-1::GFP (lanes
5–8). Negative controls using GFP are shown in lanes 1–4.
doi:10.1371/journal.ppat.1001075.g006
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RNA interference
RNAi was performed as previously described [34]. Bacterial
strains containing RNAi constructs were purchased from Gene-
service Ltd., and inserts were validated by sequencing.
Fertility assays
Individual L4-stage worms were placed on NGM plates with
fresh OP50 bacterial food. The worms were transferred onto fresh
plates every 12 hours, and the total progeny laid on each plate was
counted and recorded at each time point. This procedure was
continued until the worms reached the end of their reproductive
capacity.
MBP::EGL-9 protein expression
To build pSZ18, the bacterial expression vector for EGL-
9::MBP, egl-9 cDNA was amplified with two primers: 59GG-
Figure 7. Genetic interactions between swan-1 and mbk-1/DYRK to regulate Pnhr-57::GFP expression and resistance to P. aeruginosa
fast killing. A, B. Bacterially mediated RNAi was used to decrease expression of individual DYRK homologs in C. elegans, and the effects on Pnhr-
57::GFP expression was determined by protein blots. The bars show mean values from 3 replicate experiments; error bars represent standard errors.
** p,0.01. A. In swan-1(ok267), vhl-1(ok161) double mutants, mbk-1 RNAi significantly decreased expression of the reporter, but RNAi for the other
DYRK homologs did not change Pnhr-57::GFP levels relative to the empty vector control. B. In egl-9(sa307) animals, RNAi for the DYRK homologs
tested had no effect on Pnhr-57::GFP. C, D. The mbk-1(pk1389) deletion mutation suppressed Pnhr-57::GFP expression in swan-1(ok267), vhl-1(ok161)
double mutant animals (C) and in swan-1(ok267) animals expressing stabilized HIF-1(P621G) protein (D). E, F. The mbk-1(pk1389) mutation
suppressed resistance to P. aeruginosa PAO1 in swan-1(ok267) animals. In these experiments, HIF-1 protein was stabilized by either the vhl-1(ok161)
loss-of-function mutation (E) or the HIF-1(P621) stabilizing mutation (F). Each experiment was repeated at least three times with 30–50 animals for
each strain. The error bars represent standard errors. *: p,0.05; **: p,0.01. These data are presented in tabular format in Text S1.
doi:10.1371/journal.ppat.1001075.g007
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TGGATCCAAACCAACGGTATCCAGAAC and 59GGGAT-
CCGATGTAATACTCTGGGTTTGTGG. The PCR products
were cut with BamHI and PstI and ligated into the pMal-p2x
vector (from New England Biolabs). The plasmid expressing EGL-
9 fused to maltose binding protein was transformed into BL21
(DE3) bacteria, and a single colony was inoculated into liquid
media and cultured for 16 hours at 37uC. The bacterial culture
was diluted by 1:200 to 50 ml and cultured for 2.5 hours. IPTG
was added to a final concentration of 1 mM. After 4 hours, the
bacteria were pelleted and frozen in liquid nitrogen. The bacteria
were frozen at 280uC overnight before adding bacterial lysis
buffer (50 mM Tris PH 7.5, NaCl 150 mM, NP-40 0.1%),
0.25 mg/ml lysozyme, 0.01 mg/ml DNase, and 16 protease
inhibitor cocktail (from Roche). After four hours at 4uC, the lysate
was centrifuged at 12000 g for 20 min and the supernatant was
kept for further use.
P. aeruginosa fast killing assays
The fast killing assay follows the approach described previously
[27,28]. Briefly, a single P. aeruginosa PAO1 colony was inoculated
and cultured at 37uC for 16 hours in 3–5 ml brain heart infusion
(BHI) broth. The culture was then diluted 100-fold. 300 ml of
diluted bacteria was evenly spread on 60 mm diameter Petri dishes
with 7 ml BHI agar. To minimize the possibility of animals
escaping from the bacterial lawn, bacteria were spread to cover the
whole plate. The plates were incubated at 37uC for 24 hours and
then cooled to room temperature for 30 minutes. Thirty to fifty
developmentally synchronized L4-stage C. elegans were put on the
lawn and incubated at room temperature (22uC). Lids to the petri
plates remained closed during this time to keep hydrogen cyanide
from evaporating. C. elegans were scored as paralyzed or dead if
they did not move when the plate was tapped against the
microscope stage. Each data point represents at least three
independent replicate experiments.
Protein blots
The methods for protein blots have been described previously
[32]. At least three biological replicates were analyzed for each
experiment. Transgenic strains expressing epitope-tagged HIF-1
were used to assay HIF-1 protein levels and each lane of a protein
gel included lysate from 40–100 L4-stage animals. For the Pnhr-
57::GFP reporter, we used 5–50 L4 animals. The statistical
significance of differences was assessed by two-sample paired t-tests
or one way ANOVA with Bonferroni post test.
Real time PCR
The methods for real time PCR were as described previously
[32]. At least three biological replicates were analyzed for each
experiment, and each PCR reaction was performed in duplicate.
The statistical significance of differences was assessed by two-
sample paired t-tests or one way ANOVA with Bonferroni post
test.
Yeast two-hybrid assays
For yeast two-hybrid experiments, C. elegans cDNA sequences
were inserted in to the pGBKT7 and pGADT7 vectors from
Clonetech. The sequences encoding the EGL-9 catalytic domain
were amplified with two primers, egl-9-F: CCGGAATTCGG-
TCTCGCACTAAGCATTCACC and egl-9-R: CGCGGAT-
CCCCGTGGT CTCAAAAGTGATCCAAT, and cloned into
pGBKT7 (GAL4 DNA-binding domain vector). This construct
did not result in detectable autoactivation. Dr. Erik Lundquist
Figure 8. Model illustrating HIF-1 regulation. (A) The stability of HIF-1 protein is regulated by oxygen-dependent degradation. The EGL-9
enzyme hydroxylates HIF-1 protein in a reaction that requires molecular oxygen. Once modified, HIF-1 binds VHL-1, which promotes proteasomal
degradation of HIF-1. (B) In addition to its role in controlling HIF-1 protein levels, EGL-9 represses HIF-1 transcriptional activity via VHL-1-independent
pathway(s). SWAN-1 and RHY-1 also inhibit HIF-1-mediated transcription. MBK-1 acts downstream of SWAN-1 to promote HIF-1 activity. The
substrates of the MBK-1 DYRK kinase are not yet known. Combinations of mutations that both stabilize HIF-1 protein and de-repress HIF-1
transcriptional activity cause increased resistance to P. aeruginosa PAO1 fast killing.
doi:10.1371/journal.ppat.1001075.g008
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kindly provided the plasmid which expressed SWAN-1 fused to
the GAL4 transcriptional activation domain. The deletion vectors
(shown in Figure 6B) were amplified from this swan-1 prey plasmid
[38]. The primer sets are listed in Text S1.
The AH109 yeast strain was used. Transformations of plasmids
into yeast were performed as described previously [57,58]. The
negative controls included the co-transformation of pGADT7-
swan-1 plasmids with pGBKT7 (empty vector); the co-transfor-
mation of pGBKT7-egl-9 and pGADT7; and the co-transforma-
tion of pGBKT and pGADT7. To test for interactions, yeast
colonies carrying both plasmids (selected on Leu2, Trp2 plates)
were cultured in 2 ml Leu2/Trp2 liquid SD-medium for 24 hours
at 30uC. Twenty individual colonies were then assayed for growth
on Ade2/His2/Leu2/Trp2 X-a-gal SD-medium plates. Addi-
tionally, six Leu+/Trp+ colonies were cultured for quantification of
the b-galactosidase activity using O-nitrophenyl-B-D-galactopyr-
anoside as a substrate.
Co-immunoprecipitation experiments
The C. elegans strain expressing SWAN-1::GFP [transgenic array
lqEx19 (Pswan-1:: swan-1::gfp)] was generously provided by Erik
Lundquist. C. elegans were grown on 100 mm enriched media
plates with NA22 bacteria, and 0.4 ml mixed-stage worms were
harvested. Animals were washed with cold M9 buffer three times
and were washed once with worm lysis buffer (50 mM Tris-HCl
PH 7.4, 150 mM NaCl, 0.5% Triton-X-100, 10% glycerol, 1 mM
DTT, and 1X protease inhibitor cocktail from Roche). The worm
pellet was resuspended in 1.2 ml worm lysis buffer, and the
animals were lysed in a french press (Thermo Electron
Corporation) three times at 1000 psi. To perform immunoprecip-
itations, 80 ml G-Sepharose beads were washed with worm lysis
buffer three times for 10 minutes each, and they were then
incubated with 80 ml 0.4 mg/ml GFP antibody (Roche) overnight.
Beads were washed with worm lysis buffer three times for 5
minutes and divided into two 40 ml aliquots, each of which was
incubated with 600 ml of SWAN-1::GFP or GFP worm lysate at
4uC for 4 hours. Beads with either control GFP [Pnhr-57::GFP] or
SWAN-1::GFP were washed (three times 10 minutes in cold lysis
buffer) and incubated with MBP::EGL-9. After four hours
incubation at 4uC, beads were washed with worm lysis buffer
and boiled in 40 ml 1xSDS buffer. The proteins were fractionated
by 10% SDS polyacrylamide gel electrophoresis, and blots were
probed with maltose binding protein rabbit antiserum (from NEB
at 1:3000 dilution) or mouse GFP monoclonal antibody (clones 7.1
and 13.1 from Roche at 1:1000 dilution).
Supporting Information
Text S1 Supplemental data tables
Found at: doi:10.1371/journal.ppat.1001075.s001 (0.54 MB
DOC)
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